Modalis Therapeutics Corporation

4883.T · JPX
Analyze with AI
¥61+¥1 (+1.67%)
At close:Jan 9, 2026, 6:30 AM UTC
P/E TTM-2.28
P/B TTM1.75
P/S TTM0
Dividend Yield0%
EPS-28.57
Beta0.032
Valuation
PEG Ratio0.14
FCF Yield0.00%
EV / EBITDA-0.57
Quality
ROIC-69.50%
Gross Margin0.00%
Cash Conv. Ratio
Growth
Revenue 3Y CAGR-100.00%
FCF Growth37.57%
Safety
Net Debt / EBITDA1.06
Interest Coverage-237.69
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Modalis Therapeutics Corporation (4883.T) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Modalis Therapeutics Corporation (4883.T) stock price today?

As of Jan 9, 2026, 6:30 AM UTC, Modalis Therapeutics Corporation (4883.T) stock is trading at ¥61. The stock price is quoted in JPY and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date 4883.T stock quotes for informed trading decisions.

What is Modalis Therapeutics Corporation's market capitalization?

Modalis Therapeutics Corporation (4883.T) has a market capitalization of approximately $4.7B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Modalis Therapeutics Corporation's size relative to other companies in the JPY market. The market cap figure updates automatically as the 4883.T stock price changes.

What is the 52-week range for Modalis Therapeutics Corporation stock?

Modalis Therapeutics Corporation (4883.T) stock has traded in a 52-week range of ¥52 — ¥119. The 52-week range shows the highest and lowest prices at which 4883.T traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Modalis Therapeutics Corporation stock price to this range provides context for recent price action.

How much trading volume does Modalis Therapeutics Corporation stock have?

Modalis Therapeutics Corporation (4883.T) stock recently traded approximately 616.3K shares. Trading volume indicates market liquidity and investor interest in 4883.T. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Modalis Therapeutics Corporation stock.

Does Modalis Therapeutics Corporation pay dividends to shareholders?

Yes, Modalis Therapeutics Corporation (4883.T) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Modalis Therapeutics Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Modalis Therapeutics Corporation's intraday price range?

Today, Modalis Therapeutics Corporation (4883.T) stock has traded in a range of ¥60 — ¥61. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring 4883.T's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Modalis Therapeutics Corporation stock data?

AlphaPilot sources real-time 4883.T stock quotes, fundamental financial data, and historical price charts for Modalis Therapeutics Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Modalis Therapeutics Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of 4883.T stock performance.